CD274 and cancer: In vitro and in vivo works showed that human Vγ9Vδ2 T cells could inhibit growth of MDA-MB-231 cells, a type of TNBC cancer cells; however, the combination with anti-PD-L1 treatment could not increase their antitumor capacity.